AIDA ONCOLOGY LIMITED

🏛️Establishedactive
12557227 · ltd · incorporated 2020-04-15
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
Why now
Window steady · low confidence
Stable recent picture — watch for any upcoming trigger event.
What changed my view
Last 30 days

No material changes in the last 30 days.

Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value
Upgrade to see
Turnover
year to Apr 2025
Net worth
£-10.5k
book net assets
Opportunity
77/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 77/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
3 connected companies via shared directors
54
Filing history
14 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
77/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Negative net assets
Liabilities exceed assets by £10,509
Cash YoY
-7%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£16k
↓ 7.1% YoY
Net Worth
-£11k
↓ 13% YoY
Current Assets
£22k
↓ 5.3% YoY
Current Liabilities
-£11k-£4k£3k£10k£17k£23kApr 2024Apr 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-04-302024-04-30
Total assets£-10.5k£-9.3k
Current assets£22.1k£23.3k
Cash£16.4k£17.7k
Debtors£5.7k£5.7k
Net assets£-10.5k£-9.3k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
2
filings
  • 1 confirmation-statement
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (12 events)Click to expand
  1. 2026-04-01
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-01-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2024-01-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  4. 2023-02-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2022-12-06
    ✏️
    certificate-change-of-name-company
    change-of-name · CERTNM
  6. 2022-01-13
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2021-03-03
    GARDINER, Andrew David appointed
    director
  8. 2021-03-03
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  9. 2020-04-15
    🏢
    Company incorporated
    As AIDA ONCOLOGY LIMITED
  10. 2020-04-15
    BUHL, Peter appointed
    director
  11. 2020-04-15
    GOLDSMITH, Neil appointed
    director
  12. 2020-04-15
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

65/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Founder age: Director aged approximately 71 — succession pressure is live.

Succession & seller-readiness

60/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 71 years old. Natural succession window is now.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Mr Peter Buhl
Individual · Danish · DOB 04/1955 · age 71
5075%
50–75%board control50-75% shares · 50-75% voting · board control15/04/2020

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · NW postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ANTHONY STRATHERN LTD
14111352 · est 2022 · no financials extracted
3y
AORD PROJECT MANAGEMENT LIMITED
10591212 · est 2017 · no financials extracted
9y
APORT (LONDON) LTD
07077475 · est 2009 · no financials extracted
16y
APPLIED NANODETECTORS LIMITED
05220538 · est 2004 · no financials extracted
21y
APTITUDE ACCOUNTING LIMITED
09966766 · est 2016 · no financials extracted
10y
AQUA BRIGHT SOLUTIONS LIMITED
15478816 · est 2024 · no financials extracted
2y
AQUA SPAZIO LTD
15931839 · est 2024 · no financials extracted
1y
ARBEL (LONDON) LTD
13643821 · est 2021 · no financials extracted
4y
ARBIE LIMITED
09447334 · est 2015 · no financials extracted
11y
ARC LINE PRODUCTIONS LIMITED
10204014 · est 2016 · no financials extracted
9y
ARCC INNOVATIONS LIMITED
08028128 · est 2012 · no financials extracted
14y
ARCHESTRA LIMITED
16564691 · est 2025 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2020-04-15
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

London Bioscience Innovation Centre
2 Royal College Street
London
NW1 0NH
United Kingdom

Filing status

Accounts
Next due: 2027-01-31
Last made up to: 2025-04-30
Confirmation statement
Next due: 2027-04-28
Last: 2026-04-14

Officers (3 active · 0 resigned)

BUHL, Peter
director · ~71y · appointed 2020-04-15
View their other companies + combined net worth →
Active
GARDINER, Andrew David
director · ~63y · appointed 2021-03-03
View their other companies + combined net worth →
Active
GOLDSMITH, Neil
director · ~63y · appointed 2020-04-15
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (14 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-04-21
accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-04-01
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-04-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-01-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-17
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-01-30
confirmation-statement-with-updates
confirmation-statement · CS01
2023-04-17
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-02-28
certificate-change-of-name-company
change-of-name · CERTNM
2022-12-06
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-04-25
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-01-13
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-04-16
appoint-person-director-company-with-name-date
officers · AP01
2021-03-03
incorporation-company
incorporation · NEWINC
2020-04-15